Skip to Main content Skip to Navigation
Master Thesis

Quel impact une filiale comme la France peut avoir dans la prise de décision globale sur la stratégie d’accès au marché ? Analyse des déterminants de l’ASMR pour les médicaments en immunologie

Abstract : Market access is a vast and complex but also key area in the drug life cycle and in the strategic plan of a pharmaceutical company. However, in the case of a foreign laboratory wishing to successfully launch a drug in France, understanding market access in France and the major challenges of recent years is essential. Indeed, without this, a good market access strategy is impossible because each country has its own characteristics and a good knowledge of the specificities of each one is essential for a successful launch. We will try to understand how, through the tool that allows us to analyze the determinants of ASMR and thanks to the different projects set up by a subsidiary like France, the global can be influenced and meet the country's expectations. Thus, following the analysis of the determinants of ASMR, it emerged that the most important elements in the decision of the CT concern the design of phase III studies, the coverage of medical need and tolerance. A subsidiary can also set up tools such as Horizon Scanning and use them as a basis for argumentation during question points organized with the global, but also organize events to improve the knowledge of the French system of the parent company. Thus, by having a better knowledge of the French system, the global will be able to better anticipate France's needs in terms of clinical studies, which will ultimately affect the reimbursement as well as the price of a product.
Document type :
Master Thesis
Complete list of metadatas

Cited literature [44 references]  Display  Hide  Download

https://dumas.ccsd.cnrs.fr/dumas-02959171
Contributor : Frédérique Gambade <>
Submitted on : Tuesday, October 6, 2020 - 3:32:25 PM
Last modification on : Saturday, October 10, 2020 - 3:09:08 AM

File

Pharmacie_2020_Abalan.pdf
Files produced by the author(s)

Identifiers

  • HAL Id : dumas-02959171, version 1

Collections

Citation

Marie-Emilie Abalan. Quel impact une filiale comme la France peut avoir dans la prise de décision globale sur la stratégie d’accès au marché ? Analyse des déterminants de l’ASMR pour les médicaments en immunologie. Sciences du Vivant [q-bio]. 2020. ⟨dumas-02959171⟩

Share

Metrics

Record views

26

Files downloads

18